In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a
seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was …

Background In late December, 2019, patients presenting with viral pneumonia due to an
unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was …

Methods| We investigated the biodistribution of SARS-CoV-2 among different tissues of
inpatients with coronavirus disease 2019 (COVID-19) diagnosed based on symptoms and …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke
out in 2019 and subsequently spread worldwide. Chloroquine has been sporadically used …

An in-depth annotation of the newly discovered coronavirus (2019-nCoV) genome has
revealed differences between 2019-nCoV and severe acute respiratory syndrome (SARS) or …

Background The ongoing COVID-19 pandemic warrants accelerated efforts to test vaccine
candidates. We aimed to assess the safety and immunogenicity of an inactivated severe …

Severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) causes the infectious
disease COVID-19 (coronavirus disease 2019), which was first reported in Wuhan, China, in …

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The development of a …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus
disease 2019 (COVID-19), which has become a public health emergency of international …

Neutralizing antibodies could potentially be used as antivirals against the coronavirus disease
2019 (COVID-19) pandemic. Here, we report isolation of four human-origin monoclonal …